Recent Headlines
- Harvest One Cannabis Inc. Announces Name Change
- Harvest One and Its Brands, LivRelief (TM) and Dream Water (TM), Report Continued Improvement in Adjusted EBITDA(1) Results for Fiscal Q3 2022
- Harvest One Announces Supply Agreement with Canopy Growth's Spectrum Therapeutics' Online Medical Store
- Harvest One Brands, Dream Water(TM) and LivRelief(TM), Reach Agreement with E-Commerce Leader Flat River Group to Increase E-Commerce Distribution in the United States
- Harvest One Continues International Expansion with Sales and Distribution Agreement for Dream Water(TM) and LivRelief(TM) Products in Africa
- Harvest One and Its Brands LivRelief(TM) and Dream Water(TM) Report Continued Improvement in Adjusted EBITDA(1) Results for Fiscal Q2 2022
- Harvest One Continues to Expand its Licensed LivRelief InfusedTM Product Line with the Listing of Extra Strength Transdermal CBD Cream at the OCS
- Harvest One and its Brands LivRelief (TM) and Dream Water (TM) Report Continued Positive Results for Fiscal Q1 2022
- The Power Play by The Market Herald Releases New Interviews
- Harvest One and its Brands LivRelief (TM) and Dream Water (TM) Report Positive Q4 2021 and Year End Financial Results
- Harvest One Announces Warrants Issued for Consulting Services
- Harvest One's Dream Water (TM) Brand Launches its Sleep Gummies into the American Market
- Does Harvest One Cannabis (CVE:HVT) Have A Healthy Balance Sheet?
- Harvest One Cannabis Company Enters into Licence Agreement with The Valens Company to Manufacture and Distribute its Leading Infused Topical Brand LivRelief(TM) by Delivra
- Harvest One Announces Warrants to Be Granted for Consulting Services
- Harvest One Continues International Expansion with WB Canna Co. & Wellness for Distribution in the Caribbean, Central America and Cruise / Travel Retail
- Harvest One Adds 11,000+ New Distribution Points in U.S. for the Dream Water Brand Further Enhancing the Global Growth Strategy
- Harvest One Reports Q3 2021 Financial Results
- Harvest One Continues Expansion of Its Infused LivRelief Product Portfolio with the Launch of "Extra Strength" Transdermal CBD Cream
- Harvest One Announces Grant of Incentive Stock Options
- Harvest One Concludes Its Strategic Review Process and Provides Overview on Strategic Growth Initiatives for 2021
- Harvest One Announces Closing of $5.75 Million Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option
- Harvest One Completes Sale of Satipharm for Approximately $4 Million
- Harvest One Reports Q2 2021 Financial Results
- Harvest One Announces Upsized Bought-Deal Public Offering To $5 Million
- Harvest One Announces C$4 Million Bought Deal Equity Unit Financing
- Harvest One Announces Agreement to Sell Satipharm for Approximately $4 Million and Imminent Completion of Its Strategic Review Process
- Introducing Harvest One Cannabis (CVE:HVT), The Stock That Soared 345% In The Last Year
- Harvest One Continues International Expansion with Asian Distribution Agreement for Dream Water Products
- Harvest One's LivRelief CBD Cream is the Number One Selling SKU for Cannabis-Infused Topicals in Ontario
- Harvest One Expands Distribution of Dream Water Products in the United States and Internationally
- Harvest One Expands Distribution for LivRelief Infused Topicals
- Harvest One Reports Q1 2021 Financial Results and Provides Commercial Update
- Harvest One Subsidiary Satipharm Granted US Patent Covering Gelpell(TM) Technology
- Harvest One Reports Fourth and Year End Financial Results for 2020
- Harvest One Completes the Sale of its Non-Core Interest in Greenbelt Greenhouse for Cash Proceeds of Approximately $2.85 million
- Harvest One Announces Management and Board Changes
- Harvest One Completes Sale of Duncan Facility for $8.2 million and Commences Cannabis 2.0 Licence Agreement
- Harvest One Announces Adoption of a New Fixed Share Option Plan
- Harvest One Announces Update to Shareholder Loan
- Harvest One Announces Management Changes
- Harvest One Announces Sale of Duncan Facility for $8.2 million, Cannabis 2.0 Licence Agreement, $1.5 Million Bridge Financing and Q3 2020 Financial Results
- Harvest One Announces Update to Shareholder Loan
- Harvest One Announces the Postponement of Filing Interim Financial Statements and Management's Discussion and Analysis Due to COVID-19
- Harvest One Comments on Market Trading Activity
- Harvest One Expands Satipharms Proprietary Gelpell Product Offerings
- MMJ Group Holdings Limited - Early Warning Report
- Harvest One Announces Issuance of Warrants
- Harvest One Completes Sale of the Lillooet Property
- Harvest One Announces Leadership Changes